Table 2.
Inverse variance weighted | MR-Egger | ||||
---|---|---|---|---|---|
Panel | Immune traits | Q | P | Intercept | P |
cDC | CD62L− monocyte %monocyte | 17.81 | 0.600 | 0.005 | 0.850 |
Treg | Secreting Treg % CD4 Treg | 32.24 | 0.265 | 0.009 | 0.575 |
Treg | CD28−DN (CD4−CD8−) % DN | 28.29 | 0.344 | 0.015 | 0.404 |
B cell | CD28 on CD28+DN (CD4−CD8−) | 0.33 | 0.847 | −0.055 | 0.765 |
B cell | IgD on IgD+CD38dim | 20.34 | 0.500 | 0.008 | 0.655 |
B cell | CD40 on CD14−CD16+monocyte | 31.29 | 0.179 | −0.008 | 0.705 |
B cell | CCR2 on monocyte | 20.29 | 0.624 | −0.019 | 0.303 |
TBNK | CD45 on HLADR+CD8br | 4.71 | 0.997 | 0.009 | 0.592 |
cDC | CD11c+CD62L−monocyte AC | 13.54 | 0.889 | −0.006 | 0.019 |
Treg | Resting Treg%CD4 Treg | 25.49 | 0.601 | -0.038 | 0.062 |
Treg | Activated & resting Treg%CD4 Treg | 29.27 | 0.253 | −0.006 | 0.749 |
Treg | CD28+DN (CD4−CD8−)%DN | 28.29 | 0.344 | −0.015 | 0.404 |
Treg | CD45RA−CD28−CD8br%T cell | 180.63 | 0.311 | 0.0005 | 0.964 |
Treg | CD45RA+CD28−CD8br AC | 733.87 | 0.131 | −0.009 | 0.167 |
Treg | CD28 on secreting Treg | 15.73 | 0.330 | −0.019 | 0.352 |
Treg | CD28 on activated & secreting Treg | 19.45 | 0.617 | −0.001 | 0.936 |
B cell | CD19 on IgD+CD38− | 30.79 | 0.375 | 0.021 | 0.195 |
B cell | CD19 on IgD+CD38−naïve | 17.57 | 0.484 | −0.010 | 0.508 |
B cell | CD20 on IgD+CD38− | 20.67 | 0.658 | −0.033 | 0.061 |
B cell | CD20 on IgD−CD24− | 11.80 | 0.988 | −0.012 | 0.450 |
B cell | CD20 on IgD−CD27− | 16.26 | 0.505 | 0.028 | 0.355 |
Maturation stages of T cell | CM DN (CD4−CD8−) AC | 0.176 | 0.981 | 0.025 | 0.741 |
Maturation stages of T cell | HVEM on CM CD4+ | 14.58 | 0.482 | 0.019 | 0.401 |
Maturation stages of T cell | HVEM on CD8br | 23.59 | 0.051 | -0.010 | 0.814 |
Monocyte | CX3CR1 on monocyte | 32.34 | 0.148 | 0.021 | 0.477 |
TBNK | T cell %lymphocyte | 19.20 | 0.258 | 0.029 | 0.527 |
MR, Mendelian randomization.